Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential. (2021)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s41927-021-00192-5
PubMed Identifier: 34210348
Publication URI: http://europepmc.org/abstract/MED/34210348
Type: Journal Article/Review
Volume: 5
Parent Publication: BMC rheumatology
Issue: 1
ISSN: 2520-1026